• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

COVID-19 vaccination is associated with reduced risk of new-onset atrial fibrillation following COVID-19 infection

bySiwen LiuandSimon Pan
April 29, 2026
in Cardiology, Chronic Disease, Infectious Disease, Pharma
Reading Time: 2 mins read
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Share on FacebookShare on Twitter

1. COVID-19 vaccination was associated with a reduced 24-month risk of new-onset atrial fibrillation/flutter after COVID-19 infection.

Evidence Rating Level: 2 (Good)

COVID-19 infection has been linked with cardiovascular complications such as new-onset atrial fibrillation/flutter (NOAF). While there is evidence of the COVID-19 vaccine being protective against the development of long COVID, its potential protective effect against long-term NOAF risk after COVID-19 infection is unclear. This study thus examined the effect of COVID-19 vaccination on reducing the long-term risk of NOAF in patients after COVID-19 recovery. This retrospective cohort study used data from the TriNetX Research Network and included adults >18 years with a first recorded diagnosis of COVID-19 between January 1, 2022 and June 30, 2023. Patients were split into a vaccine group and a control (unvaccinated) group. The primary outcome was NOAF incidence at 24 months, and secondary outcomes were NOAF incidence at 1, 6 and 12 months. In total, 477,500 patients were included in the study, with 238,750 propensity matched into the vaccine group (mean [SD] age, 52.5 [18.6]; 148,934 [62.4%] female), and control group (52.3 [18.6], 150193 [62.9%] female). The NOAF incidence at 24-months was lower in the vaccine group compared to the control group (1.91% vs 2.18%; hazard ratio [HR]: 0.82, 95% CI: 0.78–0.85), even after excluding patients with severe or critical COVID-19 illness (1.51% vs. 1.78%; HR: 0.79, 95% CI: 0.76-0.83). A protective effect was also observed at 1 month (HR: 0.73, 95% CI: 0.67–0.79), 6 months (HR: 0.71, 95% CI: 0.66–0.75), and 12 months (HR: 0.77, 95% CI: 0.73–0.81). Overall, this study found that COVID-19 vaccination was associated with a reduced 24-month risk of NOAF after COVID-19 infection, highlighting its potential cardioprotective benefits beyond preventing acute illness.

Click here to read this study in PLOS One

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Tags: atrial fibrillationcardiologyCOVID-19infectious diseasevaccination
Previous Post

Polycythemia is not associated with increased mortality in heart failure

Next Post

Early enteral nutrition reduces complications after pancreatoduodenectomy in high nutritional risk patients

RelatedReports

Cardiology

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

September 30, 2026
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Next Post
The TARGET: Energy density of enteral nutrition not associated with mortality

Early enteral nutrition reduces complications after pancreatoduodenectomy in high nutritional risk patients

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Invasive management for non-ST-segment elevation myocardial infarction in frail patients may not improve mortality

Jessica Lau

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors
  • Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training
  • Prognostic associations of anthropometric indices vary by clinical outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.